HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...

To reduce regulatory burden and promote ease of doing business, the Centre has amended the New Drugs and Clinical Trials ...

India, Jan. 28 -- Union Ministry of Health and Family Welfare has notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, in line with the directions of Hon'ble Prime Minister ...

Expanding R&D in pharma and biotech, strict food safety regulations, and environmental monitoring drive chromatography market growth. Challenges include high costs limiting access for smaller entities ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk ...

The Union Budget 2026–27, through the launch of the Biopharma SHAKTI Mission with a ₹10,000-crore, five-year outlay, marks a ...

This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

In the run-up to the Union Budget 2026 presentation, healthcare leaders are urging a push toward technology-driven medical ...